Fasciolosis medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 10: | Line 10: | ||
Bithionol is another drug of choice used for treatment of [[fasciola hepatica]].<ref>Ramachandran, A., 2000. Pharmacology Recall.</ref> | Bithionol is another drug of choice used for treatment of [[fasciola hepatica]].<ref>Ramachandran, A., 2000. Pharmacology Recall.</ref> | ||
===Antimicrobial Regimen=== | |||
{{PBI|Fasciola hepatica}} | |||
:*Preferred regimen: [[Triclabendazole]] 10 mg/kg PO one dose<ref>{{Cite web | title =Parasites - Fascioliasis| url = http://www.cdc.gov/parasites/fasciola/health_professionals/}}</ref> | |||
:*Note: Two-dose (double-dose) triclabendazole therapy can be given to patients who have severe or heavy Fasciola infections (many parasites) or who did not respond to single-dose therapy. | |||
:*Alternative regimen: [[Nitazoxanide]] 500mg PO bid for 7 days | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Helminthiases]] | [[Category:Helminthiases]] | ||
[[Category:Veterinary helminthology]] | [[Category:Veterinary helminthology]] | ||
Latest revision as of 15:28, 7 August 2015
|
Fasciolosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fasciolosis medical therapy On the Web |
|
American Roentgen Ray Society Images of Fasciolosis medical therapy |
|
Risk calculators and risk factors for Fasciolosis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical therapy
Anthelmintics
For high efficacy and safety, triclabendazole (Egaten®) in dose 10-12 mg/kg is drug of choice in human fasciolosis.[1] No drug alternatives are available for humans. On the other hand, nitazoxanide were successfully used in human fasciolosis treatment in Mexico.[2] Bithionol is another drug of choice used for treatment of fasciola hepatica.[3]
Antimicrobial Regimen
- Fasciola hepatica
Return to Top
- Preferred regimen: Triclabendazole 10 mg/kg PO one dose[4]
- Note: Two-dose (double-dose) triclabendazole therapy can be given to patients who have severe or heavy Fasciola infections (many parasites) or who did not respond to single-dose therapy.
- Alternative regimen: Nitazoxanide 500mg PO bid for 7 days
References
- ↑ Savioli, L., Chistulo, L., Montresor, A., 1999. New opportunities for the control of fascioliasis. Bull. WHO 77, 300.
- ↑ Rossignol, J.F., Abaza, H., Friedman, H., 1998. Successful treatment of human fascioliasis with nitazoxanide. Trans. Roy. Soc. Trop. Med. Hyg. 92, 103–104.
- ↑ Ramachandran, A., 2000. Pharmacology Recall.
- ↑ "Parasites - Fascioliasis".